Masters degrees in Genomics offer advanced study of organisms in terms of their genomes (the complete set of DNA within a single cell of an organism). Practices such as genetic recombination, DNA sequencing methods, and bioinformatics are employed to sequence, assemble, and analyse their structure and function.
Related topics and postgraduate specialisms within Genomics include Genomic Medicine, Medical Genetics and branches of Biotechnology and Biomedicine.
Courses in this field provide several specialisations for you to choose from, including Medical and Veterinary Genomics, Evolutionary Genomics, and Plant Genomics. Whether you choose a particular focus for your degree, or opt to work on a broader range, there are plenty of practical, transferrable skills which you can employ in numerous future careers.
These include: undertaking laboratory research in topics such as gene therapy; analysing genomes through 3D modelling and bioimaging; chemical examination and manipulation of tissue cultures, from individual genomes, to cells and whole organisms.
Your experience would be suitable for: technical genomics in hospitals, veterinary centres or forensics departments; consultancy in industries such as agriculture or pharmaceuticals; policy making for NGOs, private SMEs or government agencies.
Research in the Division of Genetics and Genomics aims to advance understanding of complex animal systems and the development of improved predictive models through the application of numerical and computational approaches in the analysis, interpretation, modelling and prediction of complex animal systems from the level of the DNA and other molecules, through cellular and gene networks, tissues and organs to whole organisms and interacting populations of organisms.
The biology and traits of interest include: growth and development, body composition, feed efficiency, reproductive performance, responses to infectious disease and inherited diseases.
Research encompasses basic research in bioscience and mathematical biology and strategic research to address grand challenges, e.g. food security.
Research is focussed on, but not restricted to, target species of agricultural importance including cattle, pigs, poultry, sheep; farmed fish such as salmon; and companion animals. The availability of genome sequences and the associated genomics toolkits enable genetics research in these species.
Expertise includes genetics (molecular, quantitative), physiology (neuroendocrinology, immunology), ‘omics (genomics, functional genomics) with particular strengths in mathematical biology (quantitative genetics, epidemiology, bioinformatics, modelling).
The Division has 18 Group Leaders and 4 career track fellows who supervise over 30 postgraduate students.
Studentships are of 3 or 4 years duration and students will be expected to complete a novel piece of research which will advance our understanding of the field. To help them in this goal, students will be assigned a principal and assistant supervisor, both of whom will be active scientists at the Institute. Student progress is monitored in accordance with School Postgraduate (PG) regulations by a PhD thesis committee (which includes an independent external assessor and chair). There is also dedicated secretarial support to assist these committees and the students with regard to University and Institute matters.
All student matters are overseen by the Schools PG studies committee. The Roslin Institute also has a local PG committee and will provide advice and support to students when requested. An active staff:student liaison committee and a social committee, which is headed by our postgraduate liaison officer, provide additional support.
Students are expected to attend a number of generic training courses offered by the Transkills Programme of the University and to participate in regular seminars and laboratory progress meetings. All students will also be expected to present their data at national and international meetings throughout their period of study.
In 2011 The Roslin Institute moved to a new state-of-the-art building on the University of Edinburgh's veterinary campus at Easter Bush. Our facilities include: rodent, bird and livestock animal units and associated lab areas; comprehensive bioinformatic and genomic capability; a range of bioimaging facilities; extensive molecular biology and cell biology labs; café and auditorium where we regularly host workshops and invited speakers.
The University's genomics facility Edinburgh Genomics is closely associated with the Division of Genetics and Genomics and provides access to the latest genomics technologies, including next-generation sequencing, SNP genotyping and microarray platforms (genomics.ed.ac.uk).
In addition to the Edinburgh Compute and Data Facility’s high performance computing resources, The Roslin Institute has two compute farms, including one with 256 GB of RAM, which enable the analysis of complex ‘omics data sets.
The only Master’s specialisation in the Netherlands covering the function of our epigenome, a key factor in regulating gene expression and in a wide range of diseases.
Our skin cells, liver cells and blood cells all contain the same genetic information. Yet these are different types of cells, each performing their own specific tasks. How is this possible? The explanation lies in the epigenome: a heritable, cell-type specific set of chromosomal modifications, which regulates gene expression. Radboud University is specialised in studying the epigenome and is the only university in the Netherlands to offer a Master’s programme in this field of research.
The epigenome consists of small and reversible chemical modifications of the DNA or histone proteins, such as methylation, acetylation and phosphorylation. It changes the spatial structure of DNA, resulting in gene activation or repression. These processes are crucial for our health and also play a role in many diseases, like autoimmune diseases, cancer and neurological disorders. As opposed to modifications of the genome sequence itself, epigenetic modifications are reversible. You can therefore imagine the great potential of drugs that target epigenetic enzymes, so-called epi-drugs.
In this specialisation, you’ll look at a cell as one big and complex system. You’ll study epigenetic mechanisms during development and disease from different angles. This includes studying DNA and RNA by next-generation sequencing (epigenomics) and analysing proteins by mass spectrometry (proteomics). In addition, you‘ll be trained to design computational strategies that allow the integration of these multifaceted, high-throughput data sets into one system.
- Radboud University combines various state-of-the-art technologies – such as quantitative mass spectrometry and next-generation DNA sequencing – with downstream bioinformatics analyses in one department. This is unique in Europe.
- This programme allows you to work with researchers from the Radboud Institute for Molecular Life sciences (RIMLS), one of the leading multidisciplinary research institutes within this field of study worldwide.
- We have close contacts with high-profile medically oriented groups on the Radboud campus and with international institutes (EMBL, Max-Planck, Marie Curie, Cambridge, US-based labs, etc). As a Master’s student, you can choose to perform an internship in one of these related departments.
- Radboud University coordinates BLUEPRINT, a 30 million Euro European project focusing on the epigenomics of leukaemia. Master’s students have the opportunity to participate in this project.
As a Master’s student of Medical Epigenomics you’re trained in using state-of-the art technology in combination with biological software tools to study complete networks in cells in an unbiased manner. For example, you’ll know how to study the effects of drugs in the human body.
When you enter the job market, you’ll have:
- A thorough background of epigenetic mechanisms in health and disease, which is highly relevant in strongly rising field of epi-drug development
- Extensive and partly hands-on experience in state-of-the-art ‘omics’ technologies: next-generation sequencing, quantitative mass spectrometry and single cell technologies;
- Extensive expertise in designing, executing and interpreting scientific experiments in data-driven research;
- The computational skills needed to analyse large ‘omics’ datasets.
With this background, you can become a researcher at a:
- University or research institute;
- Pharmaceutical company, such as Synthon or Johnson & Johnson;
- Food company, like Danone or Unilever;
- Start-up company making use of -omics technology.
Apart from research into genomics and epigenomics, you could also work on topics such as miniaturising workflows, improving experimental devices, the interface between biology and informatics, medicine from a systems approach.
Or you can become a:
- Biological or medical consultant;
- Biology teacher;
- Policy coordinator, regarding genetic or medical issues;
- Patent attorney;
- Clinical research associate;
Each year, the Molecular Biology department (Prof. Henk Stunnenberg, Prof. Michiel Vermeulen) and the Molecular Developmental Biology department (Prof. Gert-Jan Veenstra) at the RIMLS offer between five and ten PhD positions. Of course, many graduates also apply for a PhD position at related departments in the Netherlands, or abroad.
- Systems biology
In the Medical Epigenomics specialisation you won’t zoom in on only one particular gene, protein or signalling pathway. Instead, you’ll regard the cell as one complete system. This comprehensive view allows you to, for example, model the impact of one particular epigenetic mutation on various parts and functions of the cell, or study the effects of a drug in an unbiased manner. One of the challenges of this systems biology approach is the processing and integration of large amounts of data. That’s why you’ll also be trained in computational biology. Once graduated, this will be a great advantage: you’ll be able to bridge the gap between biology, technology and informatics , and thus have a profile that is desperately needed in modern, data-driven biology.
- Multiple OMICS approaches
Studying cells in a systems biology approach means connecting processes at the level of the genome (genomics), epigenome (epigenomics), transcriptome (transcriptomics), proteome (proteomics), etc. In the Medical Epigenomics specialisation, you’ll get acquainted with all these different fields of study.
- Patient and animal samples
Numerous genetic diseases are not caused by genetic mutations, but by epigenetic mutations that influence the structure and function of chromatin. Think of:
- Autoimmune diseases, like rheumatoid arthritis and lupus
- Cancer, in the forms of leukaemia, colon cancer, prostate cancer and cervical cancer
- Neurological disorders, like Rett Syndrome, Alzheimer, Parkinson, Multiple Sclerosis, schizophrenia and autism
We investigate these diseases on a cellular level, focusing on the epigenetic mutations and the impact on various pathways in the cell. You’ll get the chance to participate in that research, and work with embryonic stem cell, patient, Xenopus or zebra fish samples.
See the website http://www.ru.nl/masters/medicalbiology/epigenomics
There is currently a worldwide shortage in graduates qualified in Bioinformatics and the skills to interpret the data that is going to underpin advances in biology and medicine in 21st Century. With the advent of Personalised Medicine, the demand for specialists in Computational Biology and Bioinformatics will further increase. This gives you the opportunity to build your transferable skill set across a range of cutting edge technologies and start building a career in this central facet of modern biology.
Students completing the MSc course in Bioinformatics and Computational Genomics will have the necessary skills and knowledge to undertake research and development in industry (Biotechnology, Pharmaceutical, Diagnostic companies), in medical research centres and in academic institutions worldwide.
Computational, statistical and machine learning methods form an integral part of modern research in Molecular Biology, Cell Biology, Pharmacology, Public Health Care and in Medicine. The past decade has seen enormous progress in the development of molecular and biomedical technologies. Today’s high-throughput array and sequencing techniques produce data in the range of terabytes on a daily basis and new technologies continuously emerge. This will further increase the stream of data available for biomedical research. For this reason analyzing, visualizing and managing this huge amount of data is a challenging task. The Queen’s MSc course in Bioinformatics and Computational Genomics targets these data-driven challenges of modern science. The course is open to graduates in computer science, life sciences, physics or statistics.
The programme will consist of an Introductory short course (two weeks) in Cell Biology, followed by modules in:
• Genomics & Genetics
• Analysis of Gene Expression
• Scientific Programming & Statistical Computing
• Algorithmic Biology
• Statistical Biology
• Bioimaging Informatics
• Research project : MSc dissertation
The Genomic Medicine and Healthcare course has been developed for healthcare professionals including Specialist Medical Practitioners, General Medical Practitioners, Allied Health Professionals, Nurses and Midwives, Genetic Counsellors and those with related undergraduate degrees or equivalent professional qualifications and background experience. It will be of interest to health professionals in the UK and internationally and will provide a solid foundation in the core concepts of genetics and genomics applied to modern medicine and healthcare. Although there are other courses covering the subject area, none are completely online so they are difficult and costly for global healthcare professionals to get involved. This course will reach an international audience in a cost effective, flexible and inclusive way, helping to develop a worldwide network of genomic medical and healthcare leaders.
Our course is well timed given increasing public and professional interests in genetic and genome-level diagnostic and predictive testing for clinical management, disease risk evaluation, prevention of major complications and offering the prospect of improved prognosis. Personalised benefits include the option for reproductive choices and reducing lifetime medical or health risks by judicious use of new emerging preventive medicines and devices combined with lifestyle/behaviour modifications.
Our online 1 year Postgraduate Diploma in Genomic Medicine & Healthcare is designed to be practical and clinically focused. The course will provide an integrated approach to Genomic Medicine and Healthcare and focus on applying scientific principles to direct patient care. The Genomics Diploma course is worth 120 credits and comprises 6 modules of 20 credits each.
The Diploma course aims to equip graduates with critical knowledge and understanding of genomics medicine. Graduates will be able to apply knowledge for direct clinical benefit and future study. Our Genomics Medicine Diploma course caters to the educational needs of a primary and secondary care audience and is the only one of its kind that is completely accessible online.
Our Genomic Medicine Diploma has been designed for General Medical Practitioners, Specialist Medical Practitioners (for example Paediatrics, General Medicine, Obstetrics & Gynaecology, Medical Oncology), Allied Health Professionals (Clinical Psychologists, Occupational Therapists and Physiotherapists), Nurses (Cancer, Cardiac, Paediatric, Neurology etc.) and Midwives. In addition, the course would be of interest to those with related undergraduate degrees (e.g. Dietetics, Biomedical Science, Pharmacy) or equivalent professional qualifications and background experience
On completion you will demonstrate:
- a systematic understanding of genetics and genomic factors in human diseases
- a critical awareness of current issues affecting the management of inherited human diseases
- an advanced knowledge of clinical genomics that will facilitate decision-making in unpredictable and/or complex situations
- an ability to critically evaluate current research in applied and translational genetics and genomics
- an ability to deliver management strategies for the investigation and treatment of patients with inherited human diseases
- a basic understanding of the scope and effect of genomics on treatments including horizon scanning of potential new targeted treatments for wider population
The online course lasts one calendar year and is a part time distance learning course. It consists of 6 modules per year, each of 6 weeks duration.
Module 1 - Principles of Medical Genetics and Genomics
Module 2 - Genetic Counselling
Module 3 - Genomics and Society
Module 4 - Practice of Clinical Genomics
Module 5 - Reproductive Genomics
Module 6 - Genomic Healthcare
The course puts assessment at the heart of learning by using clinical scenarios to facilitate problem-solving, critical analysis and evidence-based care. The scenarios act as both the focus for learning and assessment thus embedding assessment within the learning process.
Each of the 6 modules have the same assessment format. Due to the online nature of the course, students are expected to login and participate in the course regularly throughout the module (ideally on a daily basis).
Students are split into groups of 10-15 students and are assigned a dedicated expert tutor who:
Facilitates clinical case discussions with the group.
Monitors, assesses and marks each student throughout the module.
Students use the skills gained during the lectures to engage with the different activities (see below).
Clinical case scenarios with case based discussion - 40%
Individual learning portfolio - 10%
Group/individual activity - 20%
Case based examination - 30%
Our programme will give you cross-disciplinary skills in a rare combination of areas of expertise, from bioinformatics and evolutionary inference to computational biology and fieldwork.
You will be taught by researchers who apply genomic methods to a wide range of issues in ecology and evolution, from bat food-webs and genome evolution to microbial biodiversity in natural and engineered ecosystems. For example, Professor Steve Rossiter carries out world-leading research on bat genome evolution; Dr Yannick Wurm has discovered a social chromosome in fire-ants; and Dr China Hanson is using genetic methods to study microbial biogeography. This means that teaching on our programme is informed by the latest developments in this field, and your individual research project can be at the forefront of current scientific discovery.
You will conduct your own substantive six-month research project, which may be jointly supervised by contacts from related institutes or within industry. You will also take part in a field course in Borneo - see photos from a recent trip on Flickr - giving you the opportunity to develop first hand experience of theory in action.
By choosing to study at a Russell Group university you will have access to excellent teaching and top class research. You can find out more about our research interests and view recent publications on the School of Biological and Chemical Science's Evolution and Genetics group page.
This MSc programme combines taught modules with individual and collaborative research projects. You will apply the knowledge and techniques from your taught modules in a practical setting and may be able to publish your project findings.
If you have any questions about the content or structure, contact the programme director Dr Christophe Eizaguirre.
Genomic technologies and information will transform practice across the clinical professions over the next decade.
This MSc is a new programme developed by Health Education England and being offered by a network of centres across England. It includes study of the genomics and informatics of rare and common diseases, cancer and infectious diseases, which can be applied to clinical practice and medical research, and enhance knowledge and skills, in this rapidly evolving field.
What does our MSc provide?
This programme, delivered by the Faculty of Medicine, will provide a comprehensive perspective in genomics applied to clinical practice and medical research, with particular emphasis on the 100,000 Genomes Project. It will equip students to bring benefit to their patients through improved diagnosis and personalised treatment, and disseminate knowledge to peers, patients and the public.
Who should study?
This programme is particularly suitable for health professionals as well as students seeking to make the most of genomics as it applies to their current or future career.
Our modular structure and blended learning formats are delivered flexibly as a one year full-time or two year part-time option, or as individual or grouped modules, to facilitate access from as wide as possible a range of healthcare professionals.
Genomic technologies and information will transform practice across the clinical professions over the next decade. Our MSc Genomic Medicine degree is designed to enhance knowledge and skills in this rapidly evolving field. The masters course has been developed by Health Education England and includes study of the genomics and informatics of rare and common diseases, cancer and infectious diseases, which can be applied to clinical practice and medical research. This degree is suitable for health professionals working in the NHS, as well as students seeking to make the most of genomics as it applies to their current or future career.
This MSc Genomic Medicine has been commissioned by NHS England / Health Education England to provide education and training in genomics for health professionals from different professional backgrounds such as medicine, nursing, public health, science and technology, for whom knowledge of genomics will impact on the way they deliver their service to patients and the public.
This programme can be tailored to meet your career aspirations and enables you to choose your module options, plan your programme route, and choose from October or March to begin your studies.
You can study part-time or undertake smaller numbers of, or even individual, modules to fit your study around your other commitments.
Southampton’s MSc Genomic Medicine comprises eight core modules delivered through intensive face-to-face study and independent learning.
Our core modules include an introduction to the genetics and genomics of rare and common diseases, cancer and infectious disease, informatics analysis, and a laboratory research project or dissertation.
Optional modules within the programme include the Ethics, Counselling Skills and Teaching the Teachers to Teach.
Teaching and learning
Using a mix of learning formats, our modules include two groups of two days' intensive face-to-face teaching interspersed with independent study.
The first core module will include an additional day of student contact to incorporate an induction to the University’s facilities and introduction to basic research skills such as literature searching and critical appraisal of scientific literature).
A variety of learning and teaching methods will be adopted to promote a wide range of skills and meet differing learning styles, including seminars, group work, practical demonstrations and exercises surrounding interpretation of data and clinical scenarios.
Experts from a range of academic and health care professional backgrounds are chosen to ensure a breadth and depth of perspective, giving a good balance between theories and principles, and practical management advice.
Independent study is delivered through a virtual learning environment, delivering a library of study materials including uploaded lectures, virtual patients and independent learning tasks, reference materials, links to online tutorials, student fora, and guest lecturer web chats.
A significant component of your research will comprise either an original project or a literature-based dissertation.
What you will gain
Students who complete the programme will be equipped to harness the unprecedented transformation of the 100,000 Genomes Project, bring benefit to their patients through improved diagnosis and personalised treatment, and disseminate knowledge to peers, patients and the public.